Bacteriophage Lytic Enzyme P9ly as an Alternative Antibacterial Agent Against Antibiotic-Resistant Shigella dysenteriae and Staphylococcus aureus

Developing new strategies to replace or supplement antibiotics to combat bacterial infection is a pressing task in the field of microbiological research. In this study, we report a lytic enzyme named P9ly deriving from the bacteriophage PSD9 that could infect multidrug-resistant Shigella. This enzym...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feng, Xiao, Yao, Lu, Yao, Deng, Zheng-Yu, Deng, Xian-Yu, Lin, Lian-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882861/
https://www.ncbi.nlm.nih.gov/pubmed/35237249
http://dx.doi.org/10.3389/fmicb.2022.821989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882861/
https://www.ncbi.nlm.nih.gov/pubmed/35237249
http://dx.doi.org/10.3389/fmicb.2022.821989

Ejemplares similares